Drugs / Daivonex
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT01743118 | Mar → Jul 2013 | psoriasis | Circassia Limited | Completed | No outcome recorded |
| Phase 1 | NCT01580488 | Apr → Jun 2012 | psoriasis | LEO Pharma | Completed | No outcome recorded |
| Phase 1 | NCT01466478 | Nov → Dec 2011 | psoriasis | LEO Pharma | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02432027 Comparator | Jun → Aug 2015 | psoriasis | Prism Pharma Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Daivonex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01466478 ↗ |
| Route | Topical | “Daivonex® ointment” NCT01466478 ↗ |